Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05658354
Other study ID # 27819
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date December 31, 2024

Study information

Verified date December 2022
Source University of Ioannina
Contact Konstantinos K Tsilidis, Associate Professor
Phone 26510 0 7734
Email ktsilidi@uoi.gr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months. Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Presence of metabolic syndrome according to the criteria of IDF (2005) or revised NCEP-ATP III (2005) - Presence of mild cognitive deficit (-1.5 SD below age and education-adjusted normative mean) in previously administered neuropsychological tests of Trail Making test (Part A & B), Verbal Fluency test (animals and letter "x"), Logical Memory test (immediate and delayed recall) - Written informed consent to participate Exclusion Criteria: - Presence of any serious neurological or psychiatric condition

Study Design


Intervention

Other:
Computerized cognitive program
BrainHQ was developed by Posit Science and includes computer-based brain-training exercises organized into six categories: Attention, Brain Speed, Memory, People Skills, Intelligence, and Navigation. Participants were instructed to perform a total of 24 sessions of computerized cognitive training at home, consisting of 45 minutes of training, twice per week, over a 3-month period.

Locations

Country Name City State
Greece Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina Ioánnina

Sponsors (1)

Lead Sponsor Collaborator
University of Ioannina

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in scores of the Montreal Cognitive Assessment (MoCA) test MoCA is a screening test for mild cognitive dysfunction; range 0-30, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Complex Figure tests Complex Figures assess visuo-constructional ability and visual memory; range 0-36, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Hopkins Verbal Learning Test-Revised (HVLT-R) HVLT-R assesses verbal memory using a list of words; range 0-36 (immediate recall) and range 0-12 (delayed recall), higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Digit Span test Digit Span assesses working memory; range 0-14 (performance) and range 2-9 (span) for forward and backward condition, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of semantic Verbal Fluency test Verbal Fluency assesses executive function that also relies on language component; higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Flanker task Flanker task assesses executive function and inhibition; range 0-48, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Continuous Performance Test (CPT) CPT assesses executive function and inhibition; range 0-100, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of Set Shifting Set Shifting assesses executive function and set-shifting; range 0-104, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Primary Change in scores of N-back N-back assesses working memory; range 0-30, higher scores represent better cognitive function baseline, post-intervention (3 months), follow-up (1 year from baseline)
Secondary Change in scores of Everyday Cognition-II (Ecog-II) Ecog-II is a measure of everyday functioning that includes 41 items to assess memory, language, visual, spatial and perceptual abilities, planning, organization, and divided attention; higher scores represent worse everyday functioning baseline, follow-up (1 year from baseline)
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A